Christophe M. Deroose

9.5k citations

217 papers · 4.9k indexed · h-index 38

Radiology, Nuclear Medicine and Imaging top 0.5%
- Medical Imaging Techniques and Applications 32
- Radiopharmaceutical Chemistry and Applications 21
- Radiomics and Machine Learning in Medical Imaging 19
Oral Surgery top 1%
Oncology top 2%
- Lung Cancer Research Studies 34
Medical Laboratory Technology top 2%
Neurology top 2%
- Neuroblastoma Research and Treatments 32
Epidemiology
- Neuroendocrine Tumor Research Advances 38
Genetics
- Virus-based gene therapy research 18
Pulmonary and Respiratory Medicine
- Prostate Cancer Treatment and Research 17

Co-authors: Filip Calberson Karin Haustermans Guy Bormans Vincent Vandecaveye Frederik Cleeren Zeger Debyser R. J. G. De Moor Veerle Baekelandt
Cited by: Radiology, Nuclear Medicine and Imaging Oral Surgery Oncology
Journals: European Journal of Nuclear Medicine and Molecular Imaging (15 papers)Journal of Nuclear Medicine (12 papers)EJNMMI Research (8 papers)
Partner nations: Belgium Netherlands United States

In The Last Decade

Christophe M. Deroose

194 papers receiving 4.8k citations

Peers

Countries citing papers authored by Christophe M. Deroose

Since Specialization

Citations

This map shows the geographic impact of Christophe M. Deroose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe M. Deroose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe M. Deroose more than expected).

Fields of papers citing papers by Christophe M. Deroose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe M. Deroose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe M. Deroose. The network helps show where Christophe M. Deroose may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christophe M. Deroose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christophe M. Deroose Line = papers co-authored together Christophe M. Deroose links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lead radionuclides for theranostic applications in nuclear medicine: from atom to bedside Theranostics ·Anna Rybka,Omar Pereira Campos,Börge Fjeld Haegland,Karolien Goffin,Kristof Baete,Michel Koole,An Coosemans,T. E. Cocolios,Christophe M. Deroose,Yann Seimbille,Frederik Cleeren	2025	0
2	Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors Pharmaceuticals ·พนิต กุลศิริ,Sandra-María Sánchez-Vázquez,Frederik Cleeren,Jeroen Dekervel,Chris Verslype,Christophe M. Deroose	2025	0
3	Multicollinearity and redundancy of the PET radiomic feature set European Radiology ·이형주,Dennis Vriens,Johan Bussink,Tineke W.H. Meijer,Erik H.J.G. Aarntzen,Christophe M. Deroose,Renaud Lhommel,Nicolas Aide,Christophe Le Tourneau,E V Milz,Wim J.G. Oyen,Johannes Schautzgy,Jelle P. Ruurda,Erik Vegt,Lioe‐Fee de Geus‐Oei,Floris H. P. van Velden	2025	0
4	Clinical impact of using [ ¹⁸ F ] AlF ‐ NOTA ‐octreotide PET / CT instead of [ ⁶⁸ Ga ]Ga‐ DOTA ‐ SSA PET / CT : Secondary endpoint analysis of a multicenter, prospective trial Journal of Neuroendocrinology ·พนิต กุลศิริ,Elin Pauwels,Timon Vandamme,Xiliang Chen,Willem Lybaert,Jeroen Dekervel,Ioan Barbu,Joris Jaekers,Frederik Cleeren,Johannes Hofland,Adrienne H. Brouwers,Michel Koole,Guy Bormans,Eric Van Cutsem,Karen Geboes,Annouschka Laenen,Chris Verslype,Sigrid Stroobants,Christophe M. Deroose	2024	4
5	Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging Nuclear Medicine and Biology ·U.M. Orazalina,Xian-rong Jing,Tom Van Loy,Mike Sathekge,Christophe M. Deroose,Michel Koole,Dominique Schols,Wim Vanduffel,Kristof De Vos,Pieter Annaert,Guy Bormans,Frederik Cleeren	2024	3
6	Effect of sleeve gastrectomy and Roux-en-Y gastric bypass on gastrointestinal physiology European Journal of Pharmaceutics and Biopharmaceutics ·Nele Steenackers,Tim Vanuytsel,Patrick Augustijns,陈则谦,Wies Deckers,Christophe M. Deroose,Gwen Falony,Matthias Lannoo,Ann Mertens,Raf Mols,Roman Vangoitsenhoven,Lucas Wauters,Bart Van der Schueren,Christophe Matthys	2023	9
7	Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study Acta Oncologica ·P. E. Beyer,Feng Jung Sherida H. Woei-A-Jin,Rita Van Ginderdeuren,Christophe M. Deroose,Annouschka Laenen,Guy S. Missotten,Dietmar Rudolf Thal,Oliver Bechter,Patrick Schöffski,Paul M. Clément	2023	2
8	Radionuclide Therapy Management Søren Holm,Jonathan Gear,Pablo Mínguez Gabiña,Melitta Huszti,Ana M. Denis-Bacelar,Ian S. Armstrong,徐元招,G. Vonderheit,Christophe M. Deroose,Nicole Utz,Seung-Mo Shin,樊愉,Pedro Fragoso Costa	2022	0
9	Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study Clinical and Translational Radiation Oncology ·William Bietsch,Susan Oleta Mattocks,Annelies Debucquoy,Ines Joye,André D’Hoore,Albert Wolthuis,Y Toyosawa,Jeroen Dekervel,Eric Van Cutsem,Raphaëla C. Dresen,Vincent Vandecaveye,Christophe M. Deroose,Xavier Sagaert,Karin Haustermans	2022	11
10	[¹⁸F]FDG-PET/CT volumetric parameters can predict outcome in untreated mantle cell lymphoma Leukemia & lymphoma ·Hanshu Chang,Gregor Verhoef,Ann Janssens,Feng Jung Sherida H. Woei-A-Jin,Annouschka Laenen,Thomas Tousseyn,Daan Dierickx,Christophe M. Deroose	2022	7
11	ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours Journal of Neuroendocrinology ·Rodney J. Hicks,Clarisse Dromain,Wouter W. de Herder,Frederico Costa,Christophe M. Deroose,Andrea Frilling,Anna Koumarianou,Eric P. Krenning,Éric Raymond,Lisa Bodei,Halfdan Sørbye,Staffan Welin,Bertram Wiedenmann,Damian Wild,James R. Howe,James C. Yao,Dermot O’Toole,Anders Sundin,Vikas Prasad	2021	13
12	Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside Pharmaceutics ·Locki Zbigniew,Wangfeng Shang,Christophe M. Deroose,Thomas Cardinaels,Andrew R. Burgoyne,Guy Bormans,Maarten Ooms,Frederik Cleeren	2021	69
13	Establishment, characterization and imaging of a first platinum-resistant penile cancer patient derived xenograft in nude mice: An eUROGEN project European Urology Open Science ·Maarten Albersen,Levin Bs,张瑞娴,Uroš Milenković,Herlinde Dumez,Gert De Meerleer,Steven Joniau,Wouter Everaerts,Igor Tsaur,Dourado Pirla,Uwe Himmelreich,Christopher Cawthorne,Christophe M. Deroose,Lien Spans,Isabelle Vanden Bempt,Eleonora Leucci,Anne‐Sophie Van Rompuy,Lara Rizzotto	2020	1
14	Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution EJNMMI Research ·Sarah Belderbos,Manuel A. González‐Gómez,Frederik Cleeren,Jens Wouters,Yolanda Piñeiro,Christophe M. Deroose,An Coosemans,Willy Gsell,Guy Bormans,J. Rivas,Uwe Himmelreich	2020	35
15	Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging Nanomaterials ·Manuel A. González‐Gómez,Sarah Belderbos,S. Yáñez‐Vilar,Yolanda Piñeiro,Frederik Cleeren,Guy Bormans,Christophe M. Deroose,Willy Gsell,Uwe Himmelreich,J. Rivas	2019	77
16	Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study European Journal of Nuclear Medicine and Molecular Imaging ·Hugo Levillain,安清芬,Lieveke Ameye,Thomas Guiot,Arthur J. A. T. Braat,Carsten H. Meyer,Bruno Vanderlinden,N. Reynaert,Alain Hendlisz,عبد العزيز دحماني,Christophe M. Deroose,Hojjat Ahmadzadehfar,Patrick Flamen	2019	48
17	Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to 18F–FDG-PET/CT BMC Cancer ·Donatienne Van Weehaeghe,Olivier Gheysens,Vincent Vandecaveye,Patrick Schöffski,Koen Van Laere,Christophe M. Deroose	2018	2
18	Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes Journal of Thoracic Oncology ·Charlotte Billiet,Dirk De Ruysscher,Stéphanie Peeters,Herbert Decaluwé,Johan Vansteenkiste,Christophe Dooms,Christophe M. Deroose,Paul De Leyn,Marc Hendrikx,Paul Bulens,C. Le Péchoux,Jeroen Mebis	2016	15
19	Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement Acta Oncologica ·Sofie Isebaert,Karin Haustermans,Laura Van den Bergh,Steven Joniau,Piet Dirix,Raymond Oyen,Christophe M. Deroose,Hendrik Van Poppel,Evelyne Lerut	2013	9
20	A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal Clinical Cancer Research ·Giuseppe Floris,Agnieszka Woźniak,Raf Sciot,Haifu Li,Lori S. Friedman,Thomas Van Looy,Jasmien Wellens,Peter Vermaelen,Christophe M. Deroose,Jonathan A. Fletcher,Maria Dêbiec‐Rychter,Patrick Schöffski	2012	59

About Christophe M. Deroose

Christophe M. Deroose is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Oncology, having authored 217 papers that have together received 4.9k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (38 papers), Lung Cancer Research Studies (34 papers), Neuroblastoma Research and Treatments (32 papers), Medical Imaging Techniques and Applications (32 papers), Radiopharmaceutical Chemistry and Applications (21 papers), Radiomics and Machine Learning in Medical Imaging (19 papers), Virus-based gene therapy research (18 papers) and Prostate Cancer Treatment and Research (17 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.6k citations), Oral Surgery (423 citations) and Oncology (1.2k citations). Christophe M. Deroose has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Filip Calberson, Karin Haustermans, Guy Bormans, Vincent Vandecaveye, Frederik Cleeren, Zeger Debyser, R. J. G. De Moor, Veerle Baekelandt, Eric Van Cutsem and Koen Van Laere. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine, EJNMMI Research, Acta Oncologica and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact